Us2.ai’s AI Echo Integration Pathways

In this interview at ACC.25, The Cardiac Wire Show spotlighted how Us2.ai is transforming echocardiography and showcased the various integration pathways now available. With FDA-cleared technology, Us2.ai fully automates expert-level echo analysis—producing results in under two minutes with no manual input and 100% reproducibility. What once took 45–60 minutes for a full echo workflow can now be completed in just 20–30 minutes. This innovation is especially impactful in the face of a global sonographer shortage and growing clinical demands.

Seamless Platform Integration via Viz.ai

Us2.ai is available through Viz.ai’s platform, which acts as a centralized marketplace for hospital-ready AI solutions. This integration significantly accelerates deployment timelines. For instance, at NorthShore Evanston (part of Endeavor Health in Chicago), onboarding was completed in just six to nine weeks—compared to the typical six to nine months—thanks to the streamlined Viz.ai pathway.

Integration with an Ultrasound Device – Fujifilm 

Echo workflows are being reimagined at the device level through Us2.ai’s partnership with Fujifilm. By integrating with the LISENDO 880 ultrasound system, Us2.ai enables an end-to-end, AI-powered experience directly at the point of care. This advancement parallels the leap from manual to automatic photography—bringing greater speed, consistency, and advanced functionality to routine echocardiography. With Fujifilm’s exceptional image quality and Us2.ai’s automated analysis, clinicians benefit from a more streamlined and efficient workflow. 

Designed for Flexible Integration

Whether through digital platforms like Viz.ai or directly within echo devices, Us2.ai is redefining echocardiography delivery. By enabling faster, standardized, and more cost-effective workflows, this innovation paves the way for scalable, precision-based cardiovascular care.